Do you want to read an article? Please log in or register.
Risk and outcomes of coronavirus disease (COVID-19) in patients with inflammatory bowel disease: a systematic review and meta-analysis
Inflammatory Bowel Disease
Related content
Inflammatory Bowel Disease
Systematic Review with Meta-analysis: The Impact of Co-occurring Immune-mediated Inflammatory Diseases on the Disease Course of Inflammatory Bowel Diseases
Inflamm Bowel Dis.
Attauabi M, Zhao M, Bendtsen F, Burisch J
doi: 10.1093/ibd/izaa167.
Inflammatory Bowel Disease
Comparative Risk of Serious Infections With Biologic and/or Immunosuppressive Therapy in Patients with Inflammatory Bowel Diseases: a Systematic Review and Meta-analysis
Clin Gastroenterol Hepatol.
Singh S, Facciorusso A, Dulai PS, Jairath V, Sandborn WJ
doi: 10.1016/j.cgh.2019.02.044.
Inflammatory Bowel Disease
The risk of rheumatoid arthritis among patients with inflammatory bowel disease: a systematic review and meta-analysis
BMC Gastroenterol.
Chen Y, Chen L, Xing C, Deng G, Zeng F, Xie T, Gu L, Yang H
doi: 10.1186/s12876-020-01339-3.
Inflammatory Bowel Disease
The Risk of Adverse Neonatal Outcomes With Maternal Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
Inflamm Bowel Dis.
Leung KK, Tandon P, Govardhanam V, Maxwell C, Huang V
doi: 10.1093/ibd/izaa122.
Further Publications
Serologic response to coronavirus disease 2019 (COVID-19) vaccination in patients with immune-mediated inflammatory diseases: a systematic review and meta-analysis
Gastroenterology
Sakuraba A, Luna A, Micic D
doi: 10.1053/j.gastro.2021.09.055
COMMENTED
Inflammatory Bowel Disease
Corticosteroids, but not TNF Antagonists, are Associated with Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results from an International Registry
★ 3
Recommended and commented by
PD Dr Luc Biedermann, Faculty Member
★ 3
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
Gastroenterology.
Brenner EJ, Ungaro RC, Gearry RB, Kaplan GG, Kissous-Hunt M, Lewis JD, Ng SC, Rahier JF, Reinisch W, Ruemmele FM, Steinwurz F, Underwood FE, Zhang X, Colombel JF, Kappelman MD
doi: 10.1053/j.gastro.2020.05.032.
Inflammatory Bowel Disease
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre
United European Gastroenterol J.
Scaldaferri F, Pugliese D, Privitera G, Onali S, Lopetuso LR, Rizzatti G, Settanni CR, Pizzoferrato M, Schiavoni E, Turchini L, Amatucci V, Napolitano D, Bernabei T, Mora V, Laterza L, Papa A, Guidi L, Rapaccini GL, Gasbarrini A, Armuzzi A
doi: 10.1177/2050640620929133.
Further Publications
Opioid use among patients with inflammatory bowel disease: A systematic review and meta-analysis
Clin Gastroenterol Hepatol
Niccum B, Moninuola O, Miller K, Khalili H
doi: 10.1016/j.cgh.2020.08.041
Hepatology
Liver injury is associated with severe Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of retrospective studies
Hepatol Res.
Parohan M, Yaghoubi S, Seraj A
doi: 10.1111/hepr.13510.